Ramipril 1.25mg capsules

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Ramipril

Disponibbli minn:

Arrow Generics Ltd

Kodiċi ATC:

C09AA05

INN (Isem Internazzjonali):

Ramipril

Dożaġġ:

1.25mg

Għamla farmaċewtika:

Oral capsule

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 02050501; GTIN: 5060034832331

Fuljett ta 'informazzjoni

PACKAGE LEAFLET: INFORMATION FOR THE USER
RAMIPRIL 1.25MG, 2.5MG, 5MG AND 10MG CAPSULES
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them even if their signs of illness are the same as yours.
•
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1.
WHAT RAMIPRIL CAPSULES ARE AND WHAT THEY ARE USED FOR
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE RAMIPRIL CAPSULES
3.
HOW TO TAKE RAMIPRIL CAPSULES
4.
POSSIBLE SIDE EFFECTS
5.
HOW TO STORE RAMIPRIL CAPSULES
6.
CONTENTS OF THE PACK AND OTHER INFORMATION
1.
WHAT RAMIPRIL CAPSULES ARE AND WHAT THEY ARE USED FOR
Ramipril capsules contain a medicine called ramipril. This belongs to
a group of medicines called ACE
inhibitors (Angiotensin Converting Enzyme Inhibitors).
RAMIPRIL CAPSULES WORK BY:

decreasing your body’s production of substances that could raise
your blood pressure

making your blood vessels relax and widen

making it easier for your heart to pump blood around your body.
RAMIPRIL CAPSULES CAN BE USED:

to treat high blood pressure (hypertension)

to reduce the risk or delay the worsening of kidney problems (whether
or not you have diabetes)

to treat your heart when it cannot pump enough blood to the rest of
your body (heart failure)

as treatment following heart attack (myocardial infarction)
complicated with heart failure.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE RAMIPRIL CAPSULES
DO NOT TAKE
Ramipril capsules and
TELL
your doctor if:

you are
ALLERGIC
to the active substance or any other ingredients of this medicine
(listed in section 6).

you are allergic to any other ACE inhibitor medicine. Signs of an
allergic reaction

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ramipril 1.25 mg Capsules.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 1.25 mg Ramipril
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Capsule, hard
Ramipril 1.25 mg Capsules
Light grey gelatin capsules, marked with “R” on the cap and
“1.25” on the
body
Ramipril 2.5 mg Capsules
Light grey and light green gelatin capsules, marked with “R” on
the cap and
“2.5” on the body
Ramipril 5 mg Capsules
Light grey and green gelatin capsules, marked with “R” on the cap
and “5” on
the body
Ramipril 10 mg Capsules
Light grey and dark green gelatin capsules, marked with “R” on the
cap and
“10” on the body.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
-
Treatment of hypertension.
-
Cardiovascular prevention: reduction of cardiovascular morbidity and
mortality in patients with:
•
manifest atherothrombotic cardiovascular disease (history of
coronary heart disease or stroke, or peripheral vascular disease)
or
•
diabetes with at least one cardiovascular risk factor (see section
5.1).
-
Treatment of renal disease:
•
Incipient glomerular diabetic nephropathy as defined by the
presence of microalbuminuria,
•
Manifest glomerular diabetic nephropathy as defined by
macroproteinuria in patients with at least one cardiovascular
risk factor (see section 5.1),
•
Manifest glomerular non diabetic nephropathy as defined by
macroproteinuria
≥
3 g/day (see section 5.1).
-
Treatment of symptomatic heart failure.
-
Secondary prevention after acute myocardial infarction: reduction of
mortality from the acute phase of myocardial infarction in patients
with
clinical signs of heart failure when started > 48 hours following
acute
myocardial infarction.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
It is recommended that Ramipril Capsules are taken each day at the
same time
of the day.
Ramipril Capsules have to be swallowed with liquid. It must not be
chewed or
crushed.
_Adults _
_ _
Diuret